Showing results (101-110 of 173) with videos related to
Sort By:
Pageof 18
Inflammatory Bowel Diseases|February 5, 2013
Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12Jan Däbritz, Jost Langhorst, Andreas Lügering, et al.The American Journal of Gastroenterology|October 23, 2013
Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel diseaseJan Däbritz, Erin Bonkowski, Claudia Chalk, et al.Plos One|August 22, 2014
Distinct kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoalJost Langhorst, Annika Frede, Markus Knott, et al.Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|December 21, 2022
[How Common are Complementary Medicine Procedures in Bavarian Acute Care Hospitals? Results of A Bavarian-wide Website Screening]Anne Kollikowski, Lisa Schiffmann, Katharina Gabriel, et al.Crohn'S & Colitis 360|February 13, 2023
Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and CalprotectinJost Langhorst, Lana Kairey, Angela Oberle, et al.Inflammatory Bowel Diseases|March 1, 2005
Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national surveyJost Langhorst, Inga B Anthonisen, Ulf Steder-Neukamm, et al.The American Journal of Gastroenterology|January 29, 2009
Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndromeJost Langhorst, Angela Junge, Andreas Rueffer, et al.Journal of Ethnopharmacology|July 3, 2017
Herbal medicinal products - Evidence and tradition from a historical perspectiveRobert Jütte, Michael Heinrich, Axel Helmstädter, et al.JMIR Research Protocols|November 9, 2019
Monitoring of Vedolizumab Infusion Therapy (MOVE-IT) Response With Fecal Inflammation Markers, Ultrasound, and Trough Serum Level in Patients With Ulcerative Colitis: Protocol for a Multicentric, Prospective, Noninterventional StudyJimmi Cording, Margit Blömacher, Berit Inga Wiebe, et al.Neurogastroenterology and Motility|September 24, 2024
Review: Food-induced mucosal alterations visualized using endomicroscopyLukas Michaja Balsiger, Monica Rusticeanu, Jost Langhorst, et al.Pageof 18